Suppr超能文献

原癌蛋白 TLS/FUS 与核基质相关,并与剪接因子 PTB、SRm160 和 SR 蛋白形成复合物。

Proto-oncoprotein TLS/FUS is associated to the nuclear matrix and complexed with splicing factors PTB, SRm160, and SR proteins.

作者信息

Meissner Michael, Lopato Sergiy, Gotzmann Josef, Sauermann Georg, Barta Andrea

机构信息

Institute of Cancer Research, Borschkegasse 8a, University of Vienna, A-1090 Vienna, Austria.

出版信息

Exp Cell Res. 2003 Feb 15;283(2):184-95. doi: 10.1016/s0014-4827(02)00046-0.

Abstract

TLS/FUS is a nucleic acid-binding protein whose N-terminal half functions as a transcriptional activator domain in fusion oncoproteins found in human leukemias and liposarcomas. Previous reports have suggested a role for TLS/FUS in transcription and splicing processes. Here we report the association of TLS/FUS with the nuclear matrix and investigate its role in splicing. Splicing of two pre-mRNAs was inhibited in a TLS/FUS-immunodepleted extract and could only be partly restored by addition of recombinant TLS/FUS or/and SR proteins, known interaction partners of TLS/FUS. The subsequent analysis of TLS/FUS immunoprecipitates revealed that, in addition to the SR proteins SC35 and SRp75, the splicing factor PTB (hnRNPI) and the splicing coactivator SRm160 are complexed with TLS/FUS, thus explaining the inability to restore splicing completely. Coimmunolocalization confirmed the nuclear matrix association and interaction of TLS/FUS with PTB, SR proteins, and SRm160. Our results suggest that the matrix protein TLS/FUS plays a role in spliceosome assembly.

摘要

TLS/FUS是一种核酸结合蛋白,其N端在人类白血病和脂肪肉瘤中发现的融合癌蛋白中作为转录激活结构域发挥作用。先前的报道表明TLS/FUS在转录和剪接过程中起作用。在此,我们报道了TLS/FUS与核基质的关联,并研究了其在剪接中的作用。在TLS/FUS免疫耗尽的提取物中,两种前体mRNA的剪接受阻,仅通过添加重组TLS/FUS或/和SR蛋白(已知的TLS/FUS相互作用伙伴)才能部分恢复。随后对TLS/FUS免疫沉淀产物的分析表明,除了SR蛋白SC35和SRp75外,剪接因子PTB(hnRNPI)和剪接共激活因子SRm160也与TLS/FUS复合,从而解释了无法完全恢复剪接的原因。共免疫定位证实了TLS/FUS与核基质的关联以及与PTB、SR蛋白和SRm160的相互作用。我们的结果表明,基质蛋白TLS/FUS在剪接体组装中起作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验